DXA-measured body composition effects of GLP-1 and dual GIP/GLP-1 receptor agonists in adults with obesity or type 2 diabetes: analysis code and data (version 2.0, revised for BMC Endocrine Disorders)
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Fields of Study & Subjects
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 22 March 2026
- Language
- EN